Our data also demonstrate that in smooth muscle cells of people with aneurysms, there is an increase in the expression of the C3 gene, which leads to the phenotypic modulation of SMCs to a synthetic phenotype and the development of inflammation. The gene discussed is C3; the disease is aneurysm.